{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:22:19Z","timestamp":1790565739449,"version":"4.1.0"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Sante publique France"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Cefiderocol exhibits excellent\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      activity against\n                      <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic>\n                      ; however, resistance can emerge. We investigated the molecular mechanisms underlying cefiderocol resistance (minimal inhibitory concentration [MIC] &gt;2 mg\/L) in 103 clinical strains collected from 61 hospitals (2021\u20132024). MICs ranged from 4 to &gt;128 mg\/L, with 39.8% of strains showing MICs &gt; 8 mg\/L. Although 37.8% were classified as difficult-to-treat resistant (DTR), acquired \u03b2-lactamases were detected in 72.8% of strains, including carbapenemases (39.8%), mainly NDM-1 (29.1%), and extended-spectrum \u03b2-lactamases (ESBLs) (38.8%). Cloning of 11 \u03b2-lactamases into pUCP24, including the acquired cephalosporinase PAC-1 and ESBLs (VEB-1 and VEB-9), resulted in marked increases in cefiderocol MICs (up to 128-fold). Introduction of six mutations in the PDC enzyme into a PAO1\u0394\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>PDC-1<\/jats:sub>\n                      background increased MICs up to 4 mg\/L and conferred cross-resistance to ceftolozane\/tazobactam, notably T70I, F121L, G157D, and E219K. Alterations in siderophore transporters or regulators were identified in 38.8% of strains, most frequently a PirR frameshift (R132\n                      <jats:italic toggle=\"yes\">fs<\/jats:italic>\n                      ), consistent with PirR inactivation, which was confirmed in the PAO1 strain to contribute to cefiderocol resistance. Overall, cefiderocol resistance in clinical strains is multifactorial, mainly involving acquired \u03b2-lactamases (ESBLs and carbapenemases) and impaired siderophore uptake (PiuA\/PiuD, PirA, and PiuC), leading to high-level resistance (&gt;8 mg\/L). The polyclonal distribution and diversity of mechanisms highlight the need for routine susceptibility testing and surveillance. Detection of NDM producers is critical, as cefiderocol should be used with caution in this context.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.00520-26","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:04:51Z","timestamp":1783695891000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Mechanisms involved in cefiderocol resistance in French\n                    <i>Pseudomonas aeruginosa<\/i>\n                    clinical strains"],"prefix":"10.1128","volume":"70","author":[{"given":"Emma","family":"Gauthier","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04asdee31","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Bact\u00e9riologie, CNRS, Chrono-environnement (UMR 6249), Universit\u00e9 Marie et Louis Pasteur, CHU Besan\u00e7on Franche-Comt\u00e9","place":["Besan\u00e7on, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Pisani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04asdee31","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Bact\u00e9riologie, CNRS, Chrono-environnement (UMR 6249), Universit\u00e9 Marie et Louis Pasteur, CHU Besan\u00e7on Franche-Comt\u00e9","place":["Besan\u00e7on, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Bour","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04asdee31","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Bact\u00e9riologie, CNRS, Chrono-environnement (UMR 6249), Universit\u00e9 Marie et Louis Pasteur, CHU Besan\u00e7on Franche-Comt\u00e9","place":["Besan\u00e7on, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Grosjean","sequence":"additional","affiliation":[{"name":"RD-Biotech Company","place":["Besan\u00e7on, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7381-5671","authenticated-orcid":true,"given":"Patrick","family":"Pl\u00e9siat","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04asdee31","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Bact\u00e9riologie, CNRS, Chrono-environnement (UMR 6249), Universit\u00e9 Marie et Louis Pasteur, CHU Besan\u00e7on Franche-Comt\u00e9","place":["Besan\u00e7on, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Safari","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02kzqn938","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille (CIIL)","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7315-1553","authenticated-orcid":true,"given":"Ruben C.","family":"Hartkoorn","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02kzqn938","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019-UMR 9017, Center for Infection and Immunity of Lille (CIIL)","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Souro","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04asdee31","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Bact\u00e9riologie, CNRS, Chrono-environnement (UMR 6249), Universit\u00e9 Marie et Louis Pasteur, CHU Besan\u00e7on Franche-Comt\u00e9","place":["Besan\u00e7on, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4846-4639","authenticated-orcid":true,"given":"Emma","family":"Pr\u00e9tot","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04asdee31","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Bact\u00e9riologie, CNRS, Chrono-environnement (UMR 6249), Universit\u00e9 Marie et Louis Pasteur, CHU Besan\u00e7on Franche-Comt\u00e9","place":["Besan\u00e7on, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4634-8550","authenticated-orcid":true,"given":"Katy","family":"Jeannot","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04asdee31","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratoire de Bact\u00e9riologie, CNRS, Chrono-environnement (UMR 6249), Universit\u00e9 Marie et Louis Pasteur, CHU Besan\u00e7on Franche-Comt\u00e9","place":["Besan\u00e7on, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.32.1700843"},{"key":"e_1_3_3_3_2","unstructured":"European Centre for Disease Prevention and Control. 2024. Antimicrobial resistance in the EU\/EEA (EARS-Net) -Annual epidemiological report 2022. ECDC. Stockholm"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00233-24"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03836-23"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02712-21"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01968-17"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01454-17"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00097-18"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01192-23"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02531-16"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01410-25"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad172"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac241"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab311"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2021.0180"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00985-22"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106917"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae183"},{"key":"e_1_3_3_20_2","series-title":"CLSI Standard M100","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2025","unstructured":"CLSI. 2025. Performance standards for antimicrobial susceptibility testing. 35th ed. CLSI Standard M100. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"35"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy378"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.12.026"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae263"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae326"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00039-22"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01117-20"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01375-19"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.08.029"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14111162"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107563"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00127-24"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00477-3"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04936-22"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02085-18"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00292-25"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2017.1344235"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00785-24"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01405-16"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01928-24"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1909"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01027-25"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266742"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007562"},{"key":"e_1_3_3_44_2","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. 2025. Breakpoint tables for interpretation of MICs and zone diameters. Version 145.0 valid from 2025-01-01. Available from: http:\/\/www.eucast.org"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.11.014"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01252-10"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00520-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00520-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:01:57Z","timestamp":1785848517000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00520-26"}},"subtitle":[],"editor":[{"given":"Alita A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,5]]}},"alternative-id":["10.1128\/aac.00520-26"],"URL":"https:\/\/doi.org\/10.1128\/aac.00520-26","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"2026-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00520-26"}}